login
login
Image header Agence Europe
Europe Daily Bulletin No. 13040
Contents Publication in full By article 27 / 40
EU RESPONSE TO COVID-19 / Health

MEPs hear representatives of pharmaceutical companies which produce vaccines

MEPs on the special committee to oversee lessons learned from the Covid-19 pandemic wanted, on Monday 10 October, to question the heads of Pfizer and CureVac, in particular about the development of vaccines and past and potential contracts between their companies and the Commission.

Franz-Werner Haas represented CureVac. The majority of MEPs deplored the absence of Albert Bourla, CEO ofPfizer (see EUROPE B13039A13).

Mr Bourla is not here, I’m sorry: I know that his presence could have...

Contents

SECTORAL POLICIES
Russian invasion of Ukraine
EXTERNAL ACTION
SECURITY - DEFENCE
INSTITUTIONAL
ECONOMY - FINANCE - BUSINESS
SOCIAL - EMPLOYMENT - ÉDUCATION
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
EU RESPONSE TO COVID-19
COUNCIL OF EUROPE
NEWS BRIEFS
ADDENDUM